Scarless Laboratories, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://scarlesslabs.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Dose Regimen Study of SLI-F06 in Healthy Volunteers
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Scarless Laboratories, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05501327
- Locations
- 🇺🇸
California Dermatology & Clinical Research Institute, Encinitas, California, United States
🇺🇸DermResearch, Austin, Texas, United States
Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Scarless Laboratories, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT03880058
- Locations
- 🇺🇸
Site 1, Chicago, Illinois, United States
🇺🇸Site 2, Saint Louis, Missouri, United States
🇺🇸Site 3, Bala-Cynwyd, Pennsylvania, United States
News
No news found